AirFlow 5 mg (Chewable Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Montelukast sodium |
| Company | Ad din pharmaceuticals ltd |
| Also available as |
Indications
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
Pharmacology
Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT1)
Dosage & Administration
- Adults and adolescents with asthma or seasonal allergic rhinitis: Montelukast 10 mg tablet once daily
- Pediatric patients 6 to 14 years of age: Montelukast 5 mg tablet once daily
- Pediatric patients 2 to 5 years of age: Montelukast 4 mg tablet once daily
- Pediatric patients 6 months to 5 years of age: Montelukast 4 mg oral granules once daily
Interaction
AirFlow has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions
Contraindications
Montelukast is contraindicated in patients who are hypersensitive to any component of this product
Side Effects
- Diarrhoea
- Fever
- Gastrointestinal discomfort
- Headache
- Nausea
- Vomiting
- Skin reactions
- Upper respiratory tract infection
- Akathisia
- Anxiety
- Arthralgia
- Asthenia
- Abnormal behavior
- Depression
- Dizziness
Pregnancy & Lactation
Montelukast crosses the placenta following oral dosing in rats and rabbits
Precautions & Warnings
AirFlow is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus
Overdose Effects
The most frequently occurring adverse experiences were consistent with the safety profile of AirFlow
Therapeutic Class
Leukotriene receptor antagonists
Storage Conditions
Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children
Chemical Structure
Molecular Formula: C35H36ClNO3S
Common Questions about AirFlow 5 mg Chewable Tablet
- AirFlow 5 mg Chew. Tablet is a selective and orally active leukotriene receptor antagonist
- AirFlow 5 mg Chew. Tablet is commonly used to treat asthma or allergic rhinitis
- The effect of AirFlow 5 mg Chew. Tablet can be observed after 1-3 hours of administration
- The effect of AirFlow 5 mg Chew. Tablet lasts for an average duration of 24 hours
- AirFlow 5 mg Chew. Tablet may be taken with or without food as prescribed by your doctor
- Use of AirFlow 5 mg Chew. Tablet in pregnant women should be avoided unless clearly needed